Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Symptom Management and Health-Related Quality of Life Steering Committee Roster

The Symptoms Management and Health-Related Quality of Life Steering Committee (SxQoLSC) addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 clinical trials to control cancer symptoms and cancer treatment side effects. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The SxQoLSC's membership comprises representatives from the NCORP Research Bases, R01 investigators, community oncologists, biostatisticians, patient advocates, and NCI Staff.

 

Co-chairs

Michelle Janelsins, Ph.D., M.P.H.
University of Rochester Medical Center
Rochester, NY

Glenn Lesser, M.D.
Wake Forest University Comprehensive Cancer Center 
Winston-Salem, NC

 

Members

Stuart G. Baker, Sc.D.
National Cancer Institute
Bethesda, MD

Erin O'Carroll Bantum, Ph.D.
University of Hawai'i Cancer Center
Honolulu, HI

Julienne Bower, Ph.D.
University of California, Los Angeles
Los Angeles, CA

David Cella, Ph.D.
Northwestern University
Chicago, IL

Winson Y. Cheung, M.D., M.P.H., FRCP
University of Calgary
Calgary, AB, Canada

Kimberly S. Corbin, M.D.
Mayo Clinic
Rochester, MN

Tracy E. Crane, Ph.D., RDN
University of Miami Sylvester Comprehensive Cancer Center 
Miami, FL

Emily Dressler, Ph.D. 
Wake Forest University School of Medicine
Winston-Salem, NC

Leanne Embry, Ph.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX

Monica Epstein, RN, OCN
National Cancer Institute
Bethesda, MD

Michael Fisch, M.D., M.P.H., FACP, FAAHPM, FASCO
AIM Specialty Health
Deerfield, IL

Pankaj Gupta, M.D.
University of Minnesota
Minneapolis, MN

Brandy Heckman-Stoddard, Ph.D., M.P.H
National Cancer Institute
Bethesda, MD

Norah Lynn Henry, M.D., Ph.D., FASCO
University of Michigan
Ann Arbor, MI

Ryan T. Hughes, M.D.
Wake Forest University School of Medicine 
Winston-Salem, NC

Andrea I. Hutton
Patient Advocate  
Santa Barbara, CA

Sarah L. Kerns, Ph.D., M.P.H.
Medical College of Wisconsin 
Milwaukee, WI

Cecilia Lee, Dr.Ph., RN
National Cancer Institute
Bethesda, MD

Nancy Lenfestey, M.H.A.
St. Baldrick's Foundation 
Cary, NC

Jennifer Le-Rademacher, Ph.D.
Mayo Clinic
Rochester, MN

Lisa Marie Lowenstein, Ph.D., M.P.H., R.D.
University of Texas MD Anderson Cancer Center
Houston, TX

Doug Midthune, M.S.
National Cancer Institute
Bethesda, MD

Karen Mustian, Ph.D., M.P.H. 
University of Rochester Medical Center
Rochester, NY

Luke Peppone, Ph.D.
University of Rochester Medical Center
Rochester, NY

Lev Sirota, Ph.D.
National Cancer Institute
Bethesda, MD

Micah A. Skeens, Ph.D., APRN, FAAN
Nationwide Children's Hospital 
Columbus, OH

Stephanie J. Sohl, Ph.D.
Wake Forest University School of Medicine
Winston-Salem, NC

Mylin A. Torres, MD
Emory University Winship Cancer Institute 
Atlanta, GA

Joseph M. Unger, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA

Lynne Wagner, Ph.D.
The University of North Carolina at Chapel Hill 
Chapel Hill, NC

Matthias Weiss, M.D.
ThedaCare Cancer Care
Appleton, WI

Jennifer A. Wenzel, Ph.D., M.S., RN
Johns Hopkins University
Baltimore, MD

Elizabeth Wulff-Burchfield, M.D.
University of Kansas Medical Center
Kansas City, KS

Jian-Lun Xu, Ph.D.
National Cancer Institute
Bethesda, MD

NCI CCCT Program Director

Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov

 

  • Updated:
Email